Pfizer drugs wilt, lower-margin units shine
NEW YORK (Reuters) - U.S. drugmaker Pfizer Inc reported quarterly results roughly in line with expectations, as falling sales of prescription drugs undermined strong demand for consumer and animal-health products that some investors want the company to sell off. Full story

